Citigroup »

Vaneck Vectors Pharmaceutical etf shares owned by Citigroup

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 200 81.37
2023-09-30 $16k 200 79.86
2023-03-31 $240k 3.1k 77.63
2022-12-31 $102k 1.3k 77.74
2022-09-30 $13k 200 65.00
2021-12-31 $15k 200 75.00
2021-03-31 $30k 435 68.97
2020-12-31 $29k 435 66.67
2020-09-30 $27k 435 62.07
2020-06-30 $27k 437 61.78
2020-03-31 $18k 337 53.41
2019-12-31 $22k 337 65.28
2019-09-30 $19k 337 56.38
2019-06-30 $20k 337 59.35
2019-03-31 $20k 337 59.35
2018-12-31 $19k 337 56.38
2018-09-30 $13M 200k 64.34
2018-06-30 $12M 200k 59.00
2018-03-31 $12M 218k 56.68
2017-12-31 $13M 218k 59.39
2017-09-30 $12M 200k 57.76
2017-06-30 $12M 200k 59.10
2017-03-31 $30M 551k 55.14
2016-12-31 $18M 351k 52.51
2016-09-30 $37M 651k 57.46
2016-06-30 $44k 755 58.28